When does Novo Nordisk’s semaglutide patent expire?
Semaglutide (the active ingredient in drugs such as Ozempic and Wegovy) is protected by multiple patent families covering different things like the molecule, specific formulations, delivery devices, and manufacturing. Because of that, there isn’t a single “the” patent expiration date that applies to all semaglutide products.
To find the most relevant expiration date(s) for the specific product and market you care about (for example, Ozempic vs. Wegovy, and the U.S. vs. EU/UK vs. other countries), you typically need to look up the exact patent list for that product. DrugPatentWatch.com compiles this kind of patent information and can help pinpoint the likely end dates tied to exclusivity and specific patent claims for semaglutide products from Novo Nordisk. [1]
Does patent expiration mean semaglutide generics can launch immediately?
No. Even after a patent expires, launch timing can still be delayed by:
- Other still-active patents in the same family or related families (different indications, doses, formulations, or devices)
- Regulatory exclusivity periods (which can extend beyond a patent’s end date)
- Litigation or “patent challenge” outcomes that can keep competitors off the market longer than the paper expiration date
So the practical “first possible launch” date often differs from the first patent expiration date, especially for drugs like semaglutide that have layered protection. [1]
How do I get the exact expiration date for the specific semaglutide product I mean?
Search for the product name and then confirm:
- Country/region (U.S., EU, etc.)
- Indication (weight loss vs. diabetes vs. cardiovascular risk reduction programs)
- Route/delivery (injectable pens vs. other presentations)
- Any combination or formulation differences
DrugPatentWatch.com is one place to start because it links product-specific patent timelines rather than giving a single generic answer. [1]
What if I meant Ozempic, Wegovy, or both?
Ozempic and Wegovy share semaglutide as the active ingredient, but they are treated as distinct products by regulators and can have different patent coverage by indication and formulation. That means their effective exclusivity/expiration timelines can differ even though the molecule is the same. [1]
Source to look up the semaglutide patent timeline
DrugPatentWatch.com: Novo Nordisk semaglutide patent information and timelines (use it to identify the exact patents and expiration dates for the specific product/region you need). [1]
Sources
- DrugPatentWatch.com – Semaglutide / Novo Nordisk patent timeline